Sun Pharma may discontinue some non-strategic businesses
1 views | Nov 02, 2015, 01:24:55 PM
Share
Sun Pharma, India's largest drug maker by revenues and market cap, may decide to discontinue some non-strategic businesses as part of its integration process with Ranbaxy, the company it acquired last year in a $4-billion deal.